BROOKS Intraday Analysis...

BROOKS Share Price

Open 74.00 Change Price %
High 76.90 1 Day 0.90 1.21
Low 73.90 1 Week -1.35 -1.76
Close 75.15 1 Month -14.40 -16.08
Volume 49726 1 Year -57.75 -43.45
52 Week High 137.30
52 Week Low 73.80
BROOKS Important Levels
Resistance 2 77.93
Resistance 1 76.79
Pivot 75.32
Support 1 73.52
Support 2 72.37
NSE INDIA Most Active Stocks
PCJEWELLER 93.70 14.41%
SOUTHBANK 18.50 -17.78%
GMRINFRA 18.30 2.52%
RCOM 13.20 1.93%
ADANIPOWER 24.95 1.22%
ASHOKLEY 109.10 1.54%
JPASSOCIAT 15.15 0.33%
PNB 78.95 4.50%
SUZLON 7.45 4.93%
ITC 284.15 3.70%
More..
NSE INDIA Top Gainers Stocks
FCSSOFT 0.25 25.00%
CORDSCABLE 67.10 19.93%
ADANIGREEN 42.45 19.92%
PUNJLLOYD 13.85 19.91%
RSSOFTWARE 47.45 18.48%
EON 47.35 18.23%
KAMATHOTEL 71.00 16.87%
SANCO 23.55 15.72%
UPL 632.10 15.01%
UPL 632.10 15.01%
More..
NSE INDIA Top Losers Stocks
PRAKASHSTL 0.10 -33.33%
RAJRAYON 0.15 -25.00%
KSERASERA 0.15 -25.00%
SOUTHBANK 18.50 -17.78%
CINELINE 41.20 -14.08%
JIKIND 0.40 -11.11%
8KMILES 276.75 -10.00%
INDOWIND 3.70 -9.76%
BKMINDST 18.10 -9.05%
SAMBHAAV 5.50 -8.33%
More..

Brooks Laboratories Limited (NSE: BROOKS)

BROOKS Technical Analysis 5
As on 23rd Jul 2018 BROOKS Share Price closed @ 75.15 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 99.32 & Strong Sell for SHORT-TERM with Stoploss of 90.87 we also expect STOCK to react on Following IMPORTANT LEVELS.
BROOKS Target for July
1st Target up-side 95.43
2nd Target up-side 103.3
3rd Target up-side 111.17
1st Target down-side 72.97
2nd Target down-side 65.1
3rd Target down-side 57.23
BROOKS Synopsis Technicals View
50 Day EMA Close is Below EMA 50 (Short Term)
Bearish
100 Day EMA Close is Below EMA 100 (Mid Term) Bearish
200 Day EMA Close is Below EMA 200 (Long Term) Bearish
MACD (12 26 9) MACD Line is Less Then SIGNAL Line Bearish
RSI (14) RSI is 31.80 Sideways
MFI (14) MFI is 46.03 Sideways
CCI (20) CCI is Below -100 Over Sold
WILLIAM %R (14) William %R is Below -80 Over Sold
ADX (14) ADX is Above 20 & +DI is Below -DI Down Trend
PSAR Stoploss For Short Sell 84.71
10 Day Avg Volume Traded 6.10 % More then 10 Day Average Volume
BROOKS Other Details
Segment EQ
Market Capital 0.00
Sector Pharmaceuticals
Industry
Offical website
BROOKS Address
BROOKS
N/A
BROOKS Latest News
Stocks to Watch: NXP Semi, Hewlett-Packard, Johnson & Johnson   Wall Street Journal (blog)   - 02nd Mar 15
Brooks Labs standalone Dec '14 sales at Rs 23.68 crore   Moneycontrol.com   - 17th Feb 15
Tesco recalls fruit drinks over 'foreign bodies' and 'unusual smell'   Daily Mail   - 28th Jan 15
Sebi slaps Rs 11.80 cr penalty on Brooks Labs and 5 executives   Business Standard   - 12th Jan 15
Brooks Laboratories Ltd clarifies on SEBI order against the firm   Equity Bulls   - 05th Dec 14
Clarification sought from Brooks Laboratories Ltd   Hindu Business Line   - 03rd Dec 14
Sebi passes orders against 8 companies for non-disclosures in IPO   Economic Times   - 02nd Dec 14
Brooks Laboratories appoints SGCO & Co as statutory auditors   Moneycontrol.com   - 12th Aug 14
SEBI imposes Rs. 53.5 cr fine in Brooks Lab IPO case   Hindu Business Line   - 31st Dec 13
IPO Crackdown-2: Brooks Laboratories   Moneylife Personal Finance site and magazine   - 13th Jan 12
Interactive Technical Analysis Chart Brooks Laboratories Limited ( BROOKS NSE INDIA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Brooks Laboratories Limited
BROOKS Business Profile
Brooks Labs is in the Pharmaceuticals sector. Brooks Laboratories Ltd. was established in 2002 and maintains its strong presence in the Pharmaceutical industry as a Contract Manufacturing Company since its inception. Brooks Laboratories Ltd is a Research and Development driven Pharmaceutical manufacturing company, in last 6 years company has successfully established itself as a reputed Contract Manufacturing company for latest molecules in Injectables and Clavulanic Acid range in Tablets and Dry Syrups. The current market capitalisation stands at Rs 28.65 crore.The company has reported a standalone sales of Rs 25.20 crore and a Net Profit of Rs 1.9 crore for the quarter ended Sep 2013. The company management includes Atul Ranchal - Chairman, Rajesh Mahajan - Managing Director, D S Maity - Director & CEO, Rajnish Bedi - Independent Director, Bhaskar Sharma - Additional Director. It is listed on the BSE with a BSE Code of 533543 and the NSE with an NSE Code of BROOKS. Its Registered office is at Village Kishanpura, Nalagarh Road,,Baddi Solan District,Himachal Pradesh - 174101.